These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 16312640)
41. Pneumonia in the older patient. Niederman MS; Brito V Clin Chest Med; 2007 Dec; 28(4):751-71, vi. PubMed ID: 17967292 [TBL] [Abstract][Full Text] [Related]
42. The role of new therapies for severe community-acquired pneumonia. Restrepo MI; Anzueto A Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331 [TBL] [Abstract][Full Text] [Related]
44. Effect of chloroquine on the bioavailability of ciprofloxacin in humans. Ilo CE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo JC; Agbasi PU; Orisakwe OE Am J Ther; 2006; 13(5):432-5. PubMed ID: 16988539 [TBL] [Abstract][Full Text] [Related]
45. [Antibiotic administration in pneumonia: view from the Mediterranean]. Rello J Enferm Infecc Microbiol Clin; 2000; 18(6):255-6. PubMed ID: 11075479 [No Abstract] [Full Text] [Related]
46. Ciprofloxacin versus cefotaxime in skin and skin structure infections: a double-blind study. Ramirez-Ronda C; Saavedra S Chemioterapia; 1987 Jun; 6(2 Suppl):432-4. PubMed ID: 3334591 [No Abstract] [Full Text] [Related]
47. Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. Heyland DK; Dodek P; Muscedere J; Day A; Cook D; Crit Care Med; 2008 Mar; 36(3):737-44. PubMed ID: 18091545 [TBL] [Abstract][Full Text] [Related]
48. Recently published papers: choose well, treat well, get well--which matters most? Kirk-Bayley J; Venn R Crit Care; 2004 Apr; 8(2):91-2. PubMed ID: 15025764 [No Abstract] [Full Text] [Related]
49. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050 [TBL] [Abstract][Full Text] [Related]
50. Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant. McPherson C; Gal P; Ransom JL Ann Pharmacother; 2008 Jul; 42(7):1134-8. PubMed ID: 18577764 [TBL] [Abstract][Full Text] [Related]
51. Tobramycin in the neonatal period. Kannan MM; Dalton HP; Escobar MR Va Med Mon (1918); 1973 Nov; 100(11):1030-4. PubMed ID: 4585132 [No Abstract] [Full Text] [Related]
52. [Bacteremia at Ullvål Hospital 1977-1979. Types of bacteria and antibiotic sensitivity]. Maeland A Tidsskr Nor Laegeforen; 1981 Aug; 101(23):1284-6. PubMed ID: 7268739 [No Abstract] [Full Text] [Related]
53. [Epidemiology and prophylaxis of septic infectious complications in patients from critical and intensive therapy surgical units]. Akinkin VG; Klimova GM; Kliuzhev VM; Karpun NA; Tikhonov IuG; Luk'ianets OB; Zhuravlev AG; Korotchenko SV Ter Arkh; 2006; 78(11):30-5. PubMed ID: 17195523 [TBL] [Abstract][Full Text] [Related]
54. Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin. Krasemann C; Von Poppel H; Wegge M; Chysky V J Chemother; 1989 Jul; 1(4 Suppl):386-8. PubMed ID: 16312452 [No Abstract] [Full Text] [Related]
55. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Pea F; Viale P Clin Infect Dis; 2006 Jun; 42(12):1764-71. PubMed ID: 16705585 [TBL] [Abstract][Full Text] [Related]
56. Microbiological surveillance of the surgical intensive care unit in Zagreb--a pivot for guideline-based therapy of severe sepsis. Mihaljević L; Bedenić B; Mihaljević S; Majerović M; Petrović P; Vasilj I Coll Antropol; 2007 Dec; 31(4):1093-7. PubMed ID: 18217465 [TBL] [Abstract][Full Text] [Related]
57. Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. Kollef MH Crit Care Med; 2006 Mar; 34(3):903-5. PubMed ID: 16505677 [No Abstract] [Full Text] [Related]
59. [Therapeutic effect of azlocillin and its combinations with other antibiotics in experimental plague infection]. Markovskaia EI; Makarovskaia LN; Ryzhkova VV; Zurabian VA Antibiot Khimioter; 1993 Jul; 38(7):37-9. PubMed ID: 8161276 [TBL] [Abstract][Full Text] [Related]
60. [The clinico-laboratory evaluation of the efficacy of Ciprobai and Cifran in treating the exacerbations of chronic pyelonephritis in patients with urolithiasis]. Savitskaia KI; Trapeznikova MF; Dutov VV; Nekhorosheva AG; Nasonov VN; Skala LZ Urol Nefrol (Mosk); 1994; (3):11-4. PubMed ID: 8079401 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]